Outcomes of Uretheroileal Suspension Technique During Open Radical Cystectomy
1 other identifier
interventional
60
1 country
1
Brief Summary
The suspension technique is reported as the puboprostatic ligaments that attach the prostate to the symphysis pubis. After the ligating the complex, including both the dorsal vein complex and the puboprostatic ligaments, this complex was sharply divided anteriorly from the prostate with a safe distance (1-2 mm), and the urethra is defined and divided. After removing the prostate, the ileal pouch is reconstructed by completely everting the mucosa and sutured outward with a running 4-0 absorbable suture around the edge. The neck of the neobladder was narrowed to ≈1 cm, for convenient passage of a 20 F catheter. Anastomotic sutures of 3-0 absorbable polyglactin were placed at the 1, 3, 5, 6, 7, 9, 11 and 12 o'clock positions
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 14, 2025
CompletedFirst Posted
Study publicly available on registry
January 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
ExpectedJanuary 22, 2025
January 1, 2025
1 year
January 14, 2025
January 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The continence rates at 1, 3, 6 and 12 months after the procedure will be evaluated
Urinary continence after urethroileal suspension technique
at 1, 3, 6 and 12 months after the procedure will be evaluated
Study Arms (2)
: group (A) 30 patients will be treated with suspension uretheroileal technique
ACTIVE COMPARATORgroup (B) 30 patients will be treated with conventional radical cystectomy and ileal neobladder
ACTIVE COMPARATORInterventions
The suspension technique is reported as the puboprostatic ligaments that attach the prostate to the symphysis pubis. After the ligating the complex, including both the dorsal vein complex and the puboprostatic ligaments, this complex was sharply divided anteriorly from the prostate with a safe distance (1-2 mm), and the urethra is defined and divided. After removing the prostate, the ileal pouch is reconstructed by completely everting the mucosa and sutured outward with a running 4-0 absorbable suture around the edge. The neck of the neobladder was narrowed to ≈1 cm, for convenient passage of a 20 F catheter. Anastomotic sutures of 3-0 absorbable polyglactin were placed at the 1, 3, 5, 6, 7, 9, 11 and 12 o'clock positions through the full thickness of the urethra
After removing the prostate, the ileal pouch is reconstructed by completely everting the mucosa and sutured outward with a running 4-0 absorbable suture around the edge. The neck of the neobladder was narrowed to ≈1 cm, for convenient passage of a 20 F catheter. Anastomotic sutures of 3-0 absorbable polyglactin were placed at the 1, 3, 5, 6, 7, 9, 11 and 12 o'clock positions through the full thickness of the urethra, including the mucosa and muscularis of the neobladder neck, ensuring mucosa-to-mucosa anastomosis
Eligibility Criteria
You may qualify if:
- Patient age \>18 years.
- Muscle-invasive bladder carcinoma (MIBC).
- Non-muscle-invasive bladder carcinoma (NMIBC) fulfilling the following criteria:
- \- (recurrent disease that is unresponsive to other treatments
- \- high-grade tumors (T1, carcinoma in situ) refractory to intravesical therapy
- Multifocal or recurrent high-grade tumors despite intravesical therapy and the tumor progression from NMIBC to MIBC).
You may not qualify if:
- NMIBC or benign disease.
- Severe hepatic renal dysfunction.
- Urethral involvement with bladder carcinoma.
- Poor overall health status.
- Severe renal dysfunction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University Hospital
Sohag, Egypt
Central Study Contacts
ahmed m mohamed, lecturer
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant lecturer urology department sohag university hospital
Study Record Dates
First Submitted
January 14, 2025
First Posted
January 20, 2025
Study Start
January 1, 2025
Primary Completion
January 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
January 22, 2025
Record last verified: 2025-01